Pharmacogenetic Association between <i>XRCC1</i> Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis

<div>Forest plots of rs1799782 (Arg194Trp) and clinical outcomes in NSCLC patients under platinum-based chemotherapy. (a) ORR in the dominant model. (b) ORR in the recessive model. (c) OS in the homozygous model. NSCLC: non-small-cell lung cancer; ORR: objective response rate; OS: overall survival.</div>

BioMed Research International

fig3

Figure 3

Figure 3: Pharmacogenetic Association between <i>XRCC1</i> Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis 

Figure 3 | Pharmacogenetic Association between XRCC1 Polymorphisms and Response to Platinum-Based Chemotherapy in Asian Patients with NSCLC: A Meta-Analysis 